MAPK3 and melanoma: Intriguingly, 24 h post treatment, fisetin increased the phosphorylation of ERK1/2 at threonine202/tyrosine204 residues in 451Lu (data not shown) and A375 melanoma cells, at doses linked to decreased cell viability (Fig. 5A, Sup.